ClinicalTrials.Veeva

Menu

Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix

Integra LifeSciences logo

Integra LifeSciences

Status

Terminated

Conditions

Foot Ulcer, Diabetic

Treatments

Other: Standard of Care Moist Wound Therapy
Device: PriMatrix Moist Wound Therapy

Study type

Interventional

Funder types

Industry

Identifiers

NCT01729286
TEI-007

Details and patient eligibility

About

The objective of this study is to compare the effectiveness of PriMatrix Moist Wound Therapy (MWT) with Standard of Care MWT for the treatment of chronic diabetic foot ulcers in subjects with diabetes mellitus and without significantly compromised arterial circulation.

Full description

This study will be a multi-center, prospective, randomized single-blinded study evaluating the efficacy of PriMatrix MWT versus Standard of Care MWT in achieving complete wound closure of chronic diabetic foot ulcers by 12 weeks (84 days). To measure wound recidivism and changes in functional quality of life, each subject will complete the Cardiff Wound Impact Schedule and the SF-36v2™ at three time points during the study i) at initial screening, ii) at completion of treatment phase, and iii)at 24 weeks (post-randomization). Additionally, the data obtained from the SF-36v2™ will be used in an economic evaluation of the treatment arms.

Enrollment

92 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Type I or Type II diabetes
  • A diabetic foot ulcer located on the foot or ankle at least one square centimeter

Exclusion criteria

  • Suspected or confirmed signs/symptoms of wound infection
  • Hypersensitivity to bovine collagen

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

92 participants in 2 patient groups

PriMatrix Moist Wound Therapy
Active Comparator group
Description:
sharp debridement, Primatrix, a dressing regimen that maintains a moist wound healing environment, and offloading
Treatment:
Other: Standard of Care Moist Wound Therapy
Device: PriMatrix Moist Wound Therapy
Standard of Care Moist Wound Therapy
Other group
Description:
sharp debridement, a dressing regimen that maintains a moist wound healing environment, and offloading
Treatment:
Other: Standard of Care Moist Wound Therapy

Trial contacts and locations

18

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems